about
Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosineNeuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis UncouplingIncreased expression and function of glutamate transporters in multiple sclerosisDual-specific phosphatase-6 (Dusp6) and ERK mediate AMPA receptor-induced oligodendrocyte deathDevelopment of a new family of conformationally restricted peptides as potent nucleators of beta-turns. Design, synthesis, structure, and biological evaluation of a beta-lactam peptide analogue of melanostatin.Neuron-astrocyte cross-talk during synaptic transmission: physiological and neuropathological implications.Increased expression of cystine/glutamate antiporter in multiple sclerosisNeuroprotection by tetracyclines.Glutamate-mediated glial injury: mechanisms and clinical importance.Excitotoxic damage to white matter.PET Imaging with [(18)F]FSPG Evidences the Role of System xc(-) on Brain Inflammation Following Cerebral Ischemia in Rats.Protecting white matter from stroke injury.Neurotransmitter signaling in the pathophysiology of microglia.Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis.P2Y1 receptor-evoked glutamate exocytosis from astrocytes: control by tumor necrosis factor-alpha and prostaglandins.A novel alternative splicing form of excitatory amino acid transporter 1 is a negative regulator of glutamate uptake.Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damageAmyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors.P2X7 receptors mediate ischemic damage to oligodendrocytes.CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity.P2X4 receptors control the fate and survival of activated microglia.Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition.In vivo PET imaging of the α4β2 nicotinic acetylcholine receptor as a marker for brain inflammation after cerebral ischemia.Expression of glutamate transporters in the adult bovine corpus callosum.Glutamate exocytosis from astrocytes controls synaptic strength.Cystine/glutamate antiporter blockage induces myelin degeneration.In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis.Zn2+ -induced ERK activation mediates PARP-1-dependent ischemic-reoxygenation damage to oligodendrocytes.Gain-of-function of P2X7 receptor gene variants in multiple sclerosis.In vivo imaging of Α7 nicotinic receptors as a novel method to monitor neuroinflammation after cerebral ischemia.Inflammation in stroke: the role of cholinergic, purinergic and glutamatergic signaling.Ischemia and StrokeCalcium Dyshomeostasis in Astrocytes After IschemiaP2X7 Receptor Blockade Prevents ATP Excitotoxicity in Oligodendrocytes and Ameliorates Experimental Autoimmune EncephalomyelitisActivation of Kainate Receptors Sensitizes Oligodendrocytes to Complement AttackExpression of glutamate transporters in rat optic nerve oligodendrocytesN-substituted pyrrolinones from enamines and α-dicarbonylsP2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitisPurinergic receptors in multiple sclerosis pathogenesisTargeting P2X4 and P2X7 receptors in multiple sclerosis
P50
Q27317185-1C02F6CE-5013-4BDD-B87E-9FEDA6993043Q27342713-AEDD248E-A4A7-40F4-96F1-C9A881F40142Q28265070-D2D0D67C-38CF-47CB-A095-1160B61F1049Q28566860-62FD09DA-3025-4117-85BC-41307C0BFEFCQ30886679-17BD0659-48E5-48D8-ABC3-9D497827F3E6Q34361216-4154060C-00ED-4FAF-AE72-7627060334FBQ35052754-8EB38F79-645E-47CA-BBE5-1E8C9E20A5A7Q35941699-A2EAF7E1-CA24-4C0D-944C-6F6617D3042CQ36277315-13F419C5-6417-418F-92C7-ED0FC2B6B1B1Q36822954-DF32C7A9-8EF7-464E-AC8B-7DAD43AE93B5Q37202278-89A57F89-1BC3-4E07-BF5F-AAE482C2BB98Q38065070-D9B76E1C-938A-475D-9FE7-7A5E6540AFF9Q38102686-1B24577D-1111-4AF1-A943-B181DAB031E0Q39996819-4C3A8BC9-D3A0-451F-868D-FEFB3B75936EQ40249093-7938B554-5353-44CE-BD08-CF4EFA5C6DCDQ40393535-B9CE28A1-1E22-4664-8E14-435ED5E92788Q42592261-5B4A188E-E6F1-49E4-A1C6-9BFF7918B85EQ43198706-20A29B15-0DB6-4BD1-B773-7A9589312CE5Q43210911-DC2E9315-39D6-4BB2-B063-4DD009B30F1AQ43653561-6A8ED86B-B6FC-40DA-AD47-DFFAABEE69B5Q46356718-F64AB1B9-3265-4FEB-87F1-A95DCF042801Q46488778-AA07DE1C-9BF5-4886-B75D-ADBF3EF48CA5Q48200554-1F9ADE71-11EC-4DC9-8A42-472005F0CD6EQ48227856-653EA615-F2F3-4408-ABD7-BD06E145CBF5Q48268662-9E351A9B-F05B-454E-8C32-443ED82268E0Q48703799-19807BB4-4AE4-48AC-8FDA-F1BC9A73352EQ49160094-D700EDC4-2BF1-47D2-B9C4-2915F040E5BBQ50497685-65376CC6-28D6-4E3A-AC54-EEDC4D0AEC09Q50526479-6C9C8489-7823-437B-9BDE-BF131BA64CC7Q51741400-9B9808D4-B862-4721-A61E-E7F6E6FF1667Q54988313-83AD9508-A8D8-463E-AC3B-27DCD6FB363FQ57975133-97260F69-AFF8-4089-86C9-C83B600B06B4Q57975134-2DA4EB3C-8503-4AF2-B270-4B24A87BC23EQ57975135-CDA386FB-6641-49AD-920C-A98F5A162B86Q57975136-299CB69D-068B-48FD-9211-D982EC643342Q57975140-C1EA98CF-29F2-4522-8B8E-DA182C50A54FQ57975141-60A581B6-EA27-4622-99C1-E5E0D1F26F71Q58669617-6D9709F3-2E23-4213-B4D5-1988C04214B1Q89998804-17EEB0DE-8AC4-40AD-894A-D25EAF39BC0FQ90249647-B26C5768-F478-45D4-BFD7-CC5DB33FA8AE
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
María Domercq
@ast
María Domercq
@en
María Domercq
@es
María Domercq
@nl
type
label
María Domercq
@ast
María Domercq
@en
María Domercq
@es
María Domercq
@nl
prefLabel
María Domercq
@ast
María Domercq
@en
María Domercq
@es
María Domercq
@nl
P106
P1153
6508165260
P21
P31
P496
0000-0002-4918-9276